Free Trial

Eli Lilly and Company (LLY) Earnings Date, Estimates & Call Transcripts

Eli Lilly and Company logo
$767.76 +10.22 (+1.35%)
(As of 12/20/2024 05:45 PM ET)

Eli Lilly and Company Latest Earnings Summary

Actual EPS
(Oct. 30)
$1.18 Missed By -$0.34
Consensus EPS
(Oct. 30)
$1.52

Eli Lilly and Company announced Q3 2024 earnings on October 30, 2024, reporting an EPS of $1.18, which missed analysts' consensus estimates of $1.52 by $0.34. Quarterly revenue rose 20.4% year-over-year to $11.44 billion, below the consensus estimate of $12.09 billion. With a trailing EPS of $9.25 and a P/E Ratio of 83.00, Eli Lilly and Company's earnings are expected to grow 79.29% next year, from $13.18 to $23.63 per share.

Get Eli Lilly and Company Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Eli Lilly and Company and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LLY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LLY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Eli Lilly and Company Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$2.34$2.74$2.54 
Q2 20243$2.41$2.89$2.64 
Q3 20243$1.24$4.39$2.85 
Q4 20243$3.04$5.52$4.67 
FY 202412$9.03$15.54$12.70 
Q1 20251$4.69$4.69$4.69 
Q2 20251$5.22$5.22$5.22 
Q3 20251$6.18$6.18$6.18 
Q4 20251$6.71$6.71$6.71 
FY 20254$22.80$22.80$22.80 
Q1 20261$6.13$6.13$6.13 
Q2 20261$6.89$6.89$6.89 
Q3 20261$7.92$7.92$7.92 

Eli Lilly and Company Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/30/2024Q3 2024$1.52$1.18 -$0.34$1.29$12.09B$11.44B
8/8/2024Q2 2024$2.64$3.92+$1.28$4.56$9.83B$11.30B
5/6/2024Q1 2024$2.53$2.58+$0.05$2.68$8.94B$8.77B
2/6/2024Q4 2023$2.30$2.49+$0.19$2.56$8.95B$9.35B
11/2/2023Q3 2023-$0.08$0.10+$0.18$0.26$8.88B$9.50B
8/8/2023Q2 2023$1.98$2.11+$0.13$2.27$7.58B$8.31B
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

4/27/2023Q1 2023$1.73$1.62 -$0.11$1.75$6.87B$6.96B
2/2/2023Q4 2022$1.83$2.09+$0.26$2.04$7.39B$7.30B

Eli Lilly and Company Earnings - Frequently Asked Questions

Eli Lilly and Company (NYSE:LLY) last announced its quarterly earning data on Wednesday, October 30, 2024. Learn more on LLY's earnings history.

Eli Lilly and Company issued an update on its FY24 earnings guidance on Wednesday, October, 30th. The company provided EPS guidance of $13.02-13.52 for the period, compared to the consensus estimate of $13.42. The company issued revenue guidance of $45.4-46.0 billion, compared to the consensus revenue estimate of $46.24 billion.

In the previous quarter, Eli Lilly and Company (NYSE:LLY) missed the analysts' consensus estimate of $1.52 by $0.34 with a reported earnings per share (EPS) of $1.18. Learn more on analysts' earnings estimate vs. LLY's actual earnings.

The conference call for Eli Lilly and Company's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Eli Lilly and Company's latest earnings report can be read online.
Read Transcript

Eli Lilly and Company's earnings report can be found in their filing with the SEC.
View SEC filing

Eli Lilly and Company (NYSE:LLY) has a recorded annual revenue of $40.86 billion.

Eli Lilly and Company (NYSE:LLY) has a recorded net income of $5.24 billion. LLY has generated $9.25 earnings per share over the last four quarters.

Eli Lilly and Company (NYSE:LLY) has a trailing price-to-earnings ratio of 83.00 and a forward price-to-earnings ratio of 58.25. The price/earnings-to-growth ratio is 3.02.

Eli Lilly and Company's earnings are expected to grow from $13.18 per share to $23.63 per share in the next year, which is a 79.29% increase.

More Earnings Resources from MarketBeat



This page (NYSE:LLY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners